Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4176db4e7d4c39336e90c85ad960e563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9647f41b85d79320d26eb6ae4b44bbf |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
filingDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7ba32b15c3a05566b6dda6f94fb0ce2 |
publicationDate |
2002-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02098918-A2 |
titleOfInvention |
Novel targets for a therapeutic intervention in ebv related diseases |
abstract |
The present invention provides a mutant RBP-J DNA binding protein capable of binding Notch protein but incapable of binding EBNA2 and to methods of isolating said mutant RBP-J protein. The present invention provides methods for identifying and producing drugs for treatment of EBV-infection or of disorders or diseases related to EBV-infection. The present invention further provides methods for treating an EBV-infection or a disorder or disease related to EBV-infection. Furthermore, the invention provises a mutant RBP-J DNA binding protein capable of binding EBNA2 protein but incapable of binding Notch. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087195-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004062686-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004062686-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087195-A3 |
priorityDate |
2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |